Spontaneous rejection of intradermally transplanted non-engineered tumor cells by neutrophils and macrophages from syngeneic strains of mice

Microbiology and Immunology

Volumn 55, Issue 10, 2011, Pages 726-735

  Ibata, Minenori ^a,b   Takahashi, Takeshi ^a   Shimizu, Tetsunosuke ^a   Inoue, Yoshihiro ^a   Maeda, Shogo ^a   Tashiro Yamaji, Junko ^a   Okada, Masashi ^b   Ueda, Koichi ^b   Kubota, Takahiro ^a   Yoshida, Ryotaro ^a  

^a Department of Physiology ^*  (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Macrophage; Neutrophil; Rodent; Spontaneous tumor rejection; T cell

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR3; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; GRANULOCYTE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MONOCYTE; MOUSE; MOUSE STRAIN; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PHENOTYPE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR GROWTH; TUMOR REJECTION; TUMOR VOLUME;

ANIMALS; CELL LINE, TUMOR; GRAFT REJECTION; HUMANS; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEUTROPHIL INFILTRATION; NEUTROPHILS;

MUS; RODENTIA;

EID: 80053335574     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00369.x     Document Type: Article

References (47)

1. Tepper R.I., Coffman R.L., Leder P. (1992) An eosinophil- dependent mechanism for the antitumor effect of interleukin-4. Science 257: 548-51.
2. Hock H., Dorsch M., Kunzendorf U., Qin Z., Diamantstein T., Blankenstein T. (1993) Mechanisms of rejection induced by tumor cell-targeted gene transfer of IL-2, IL-4, IL-7, tumor necrosis factor or interferon gamma. Proc Natl Acad Sci USA 90: 2774-8.
3. Allione A., Consalvo M., Manni F., Cavallo F., Giovarelli M., Forni G. (1994) Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants. Cancer Res 54: 6022-6.
4. Korec S., Herberman R.B., Dean J.H., Cannon G.B. (1980) Cytostasis of tumor cell lines by human granulocytes. Cell Immunol 53: 104-15.
5. Cameron D.J. (1983) A comparison of the cytotoxic potential in polymorphonuclear leukocytes obtained from normal donors and cancer patients. Clin Immunol Immunopathol 28: 115-24.
6. Lichtenstein A., Kahle J. (1985) Antitumor effect of inflammatory neutrophils: characteristics of in vivo generation and in vitro tumor cell lysis. Int J Cancer 35: 121-7.
7. Fady C., Reisser D., Martin F. (1990) Non-activated rat neutrophils kill syngeneic colon tumor cells by the release of low molecular weight factor. Immunobiol 181: 1-12.
8. Midorikama Y., Yamashita T., Sendo F. (1990) Modulation of the immune response to transplanted tumors in rats by selective depletion of neutrophils in vivo using a monoclonal antibody: abrogation of specific transplantation resistance to chemical carcinogen-induced syngeneic tumors by selective depletion of neutrophils in vivo. Cancer Res 50: 6243-7.
9. Cavallo F., Offringa R., van der Burg S.H., Forni G., Melief C.J. (2006) Vaccination for treatment and prevention of cancer in animal models. Adv Immunol 90: 175-213.
10. Dougan M., Dranoff G. (2009) Immune therapy for cancer. Annu Rev Immunol 27: 83-117.
11. Hu H., Urba W., Fox B. (1998) Gene-modified tumor vaccine with therapeutic potential shifts tumor-specific T cell response from a type 2 to a type 1 cytokine profile. J Immunol 161: 3033-41.
12. Rosenberg S., Spiess P., Lafreniere R. (1986) A new approach to adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science (Wash. DC) 233: 1318-21.
13. Tanaka H., Yoshizawa H., Yamaguchi Y., Ito K., Kagamu H., Suzuki E., Gejyo F., Hamada H., Arakawa M. (1999) Successful adoptive immunotherapy of murine poorly immunogenic tumors with specific effector cells generated from gene-modified tumor-primed lymph node cells. J Immunol 162: 3574-82.
14. Kjaergaard J., Shu S. (1999) Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires down-regulation of L-selectin expression. J Immunol 163: 751-9.
15. Mukai S., Kjaergaard J., Shu S., Plautz G. (1999) Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy. Cancer Res 59: 5245-9.
16. Fisher B., Packaj B., Read E., Carrasquillo J., Carter C., Topalian S., Rosenberg S. (1989) Tumor localization of adoptively transferred Indium-111 labelled tumor infiltrating lymphocytes in patients with metastatic melanoma. J Clin Oncol 7: 250-61.
17. Packaj B., Sherry R., Wei J., Yannelli J., Carter C., Leitman S., Carasquillo J., Steinberg S., Rosenberg S., Yang J. (1994) Localization of Indium-111 labeled tumor, infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Cancer (Phila.) 73: 1731-7.
18. Carlo E., Formi D.G., Lollini P., Modesti A., Musiani P. (2001) The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97: 339-45.
19. Noffz G., Qin Z., Kopf M., Blankenstein T. (1998) Neutrophils but not eosinophils are involved in growth suppression of IL-4- secreting tumors. J Immunol 160: 343-50.
20. Morse M.A., Chui S., Hobeika A., Lyerly H.K., Clay T. (2005) Recent developments in therapeutic cancer vaccines. Nat Clin Pract Oncol 2: 108-13.
21. Nestle F.O., Banchereau J., Hart D. (2001) Dendritic cells: on the move from bench to bedside. Nat Med 7: 761-5.
22. Lee K., Takenaka H., Yoneda Y., Goto T., Sano K., Nakanishi M., Eguchi A., Okada M., Tashiro J., Sakurai K., Kubota T., Yoshida R. (2004) Differential susceptibility of cells expressing allogeneic MHC or viral antigen to killing by antigen-specific CTL. Microbiol Immunol 48: 15-25.
23. Winn H.J. (1961) Immune mechanisms in homotransplantations II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts. J Immunol 86: 228-39.
24. Greene M.I., Fujimoto S., Sehon A.H. (1977) Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing host. J Immunol 119: 757-64.
25. + cytotoxic T-lymphocyte clones. J Exp Med 156: 1280-5.
26. Krist L.F., Kerremans M., Koenen H., Blijleven N., Eestermans I.L., Calame W., Meyer S., Beelen R.H. (1995) Novel isolation and purification method permitting functional cytotoxicity studies of macrophages from milky spots in the greater omentum. J Immunol Methods 184: 253-61.
27. Yamamoto N., Einaga-Naito K., Kuriyama M., Kawada Y., Yoshida R. (1998) Cellular basis of skin allograft rejection in mice: specific lysis of allogeneic skin components by non-T cells. Transplantation 65: 818-25.
28. 2+-dependent, Fas- and perforin-independent apoptotic death of allografted tumor cells by a type of activated macrophage. J Immunol 159: 15-21.
29. Yoshida R., Takikawa O., Oku T., Habara-Ohkubo A. (1991) Mononuclear phagocytes: A major population of effector cells responsible for rejection of allografted tumor cells in mice. Proc Natl Acad Sci USA 88: 1526-30.
30. Yoshida R., Matsuura A., Einaga K., Ushio Y., Yamamoto N., Yoneda Y. (1997) Two distinct populations of primary cytotoxic cells infiltrating into allografted tumor rejection site: Infiltration of macrophages cytotoxic against allografted tumor precedes that of multiple sets of cytotoxic T lymphocytes with distinct specificity to alloantigens. Microbiol Immunol 41: 149-59.
31. Ascher N.L., Ferguson R.M., Hoffman R., Simmons R.L. (1979) Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation 27: 254-9.
32. Yamaguchi S., Tashiro-Yamaji J., Lee K., Takahashi T., Sano K., Endo Y., Nakanishi M., Eguchi A., Okada M., Nomi H., Yamamoto Y., Takenaka H., Kubota T., Yoshida R. (2005) IFN-γ: A cytokine essential for rejection of CTL-resistant, virus-infected cells. J Interferon Cytokine Res 25: 328-37.
33. Yoneda Y., Yoshida R. (1998) The role of T cells in allografted tumor rejection: IFN-gamma released from T cells is essential for induction of effector macrophages in the rejection site. J Immunol 160: 6012-7.
34. - cells cytotoxic against the tumor cells. Cancer Immunol Immmunother 58: 2011-23.
35. + T cells. Proc Natl Acad Sci USA 91: 3171-5.
36. Cavallo F., Giovarelli M., Gulino A., Vacca A., Stoppaciaro A., Modesti A., Forni G. (1992) Role of neutrophils and CD4 T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. J Immnol 149: 3627-35.
37. Colombo M., Lombardi A., Stoppacciano C., Melani M., Parenza B., Bottazzi B., Parmiani G. (1992) Granulocyte colony-stimulating factor gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. J Immunol 149: 113-9.
38. Hirose K., Hakozaki M., Nyumoya Y., Kobayashi Y., Matsushita K., Takenouchi T., Mikata A., Mukaida M., Matsushima K. (1995) Chemokine gene transfection into tumor cells reduced tumorigenicity in nude mice in association with neutrophil infiltration. Br J Cancer 72: 708-14.
39. Shinohara H., Yano S., Bucana C.D., Fidler I.J. (2000) Induction of chemokine secretion and enhancement of contact-dependent macrophage cytotoxicity by engineered expression of granulocyte-macrophage colony-stimulating factor in human colon cancer cells. J Immunol 164: 2728-37.
40. Lee L., Hellendall R., Wang Y., Haskill J., Mukaida N., Matsushima K., Ting J. (2000) IL-8 reduced tumorigenicity of human ovarian cancer in vivo due to neutrophil infiltration. J Immunol 164: 2769-75.
41. + T cells and neutrophils expressing XCR1 receptor. J Immunol 167: 57-65.
42. Otten M.A., Rudolph E., Dechant M., Tuk C.W., Reijmers R.M., Beelen R.H., van de Winkel J.G., van Egmond M. (2005) Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J Immunol 174: 5472-80.
43. Yoshida R., Oku T., Takikawa O., Einaga-Naito K., Yoneda Y., Hirota R., Kubota T. (2000) Leukocyte integrin-dependent and antibody-independent cytotoxicity of macrophage against allografts. Microbiol Immunol 44: 57-67.
44. Yoneda Y., Tashiro-Yamaji J., Kubota T., Yoshida R. (2008) Two types of allograft-induced cytotoxic macrophage, one against allografts and the other against syngeneic or allogeneic tumor cells. Microbiol Immunol 52: 349-356.
45. b) mice. Microbiol Immunol 51: 297-306.
46. Yoshida R., Yoneda Y., Kuriyama M., Kubota T. (1999) IFN-γ- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: An application of allografting to cancer treatment. J Immunol 163: 148-154.
47. Nomi H., Tashiro-Yamaji J., Miura-Takeda S., Miyoshi-Higashino M., Takahashi T., Azuma H., Ueda H., Katsuoka Y., Kubota T., Yoshida R. (2007) Acute rejection of allografted CTL-susceptible leukemia cells from perforin/Fas ligand double-deficient mice. J Immunol 179: 2180-6.